SS

Subodh Saxena

Director Director DIN 08099930
DIN 08099930 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Subodh Saxena

Data last updated:

Subodh Saxena was a Director at Almet Lifesciences Private Limited (2020) and Director at Abbares Pharmaceuticals Private Limited (2018–2020). The companies operate in Pharma.

DIN 08099930
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Almet Lifesciences Private Limited U74999GJ2020PTC113417
Director15 Apr 20202020₹8.32 Cr (FY 2025)Active
Director31 Mar 20182018₹34.80 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Almet Lifesciences Private Limited
Abbares Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Subodh Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subodh Saxena

Subodh Saxena was first appointed on 31 Mar 2018 as Director at Abbares Pharmaceuticals Private Limited. The most recent appointment on record is 15 Apr 2020 at Almet Lifesciences Private Limited.

Subodh Saxena held 2 earlier board appointments: Almet Lifesciences Private Limited (Director, 15 Apr 2020 to 02 Sep 2020); Abbares Pharmaceuticals Private Limited (Director, 31 Mar 2018 to 20 Mar 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available